Startups
VION Biosciences is positioned to be a best-in-class life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications in the biochemical and life science sectors, from research to commercialization.
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 22, 2024 | VION Biosciences Acquires Echelon Biosciences | Vion Biosciences, a Charlottesville, VA-based life science platform company focused on specialty reagents in the life science research, diagnostic, and drug discovery space, acquired Echelon Biosciences, a Salt Lake City, UT-based supplier ... |
Reviews 0
FAQ about VION
What has the press written about VION?
Parsers VC has collected 2 articles mentioning VION, among them “VION Biosciences Acquires Echelon Biosciences” (Aug 22, 2024).
Is VION still active?
Yes, VION is active; its latest activity on Parsers VC dates from Jun 8, 2026.